KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Short-term Investments (2022 - 2026)

Staar Surgical (STAA) has disclosed Short-term Investments for 5 consecutive years, with $34.4 million as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Short-term Investments fell 60.17% year-over-year to $34.4 million, compared with a TTM value of $34.4 million through Jan 2026, down 60.17%, and an annual FY2026 reading of $34.4 million, down 60.17% over the prior year.
  • Short-term Investments was $34.4 million for Q1 2026 at Staar Surgical, up from $16.5 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $125.2 million in Q4 2022 and bottomed at $16.5 million in Q3 2025.
  • Average Short-term Investments over 5 years is $61.6 million, with a median of $55.2 million recorded in 2023.
  • The sharpest move saw Short-term Investments crashed 81.45% in 2024, then surged 135.02% in 2025.
  • Year by year, Short-term Investments stood at $125.2 million in 2022, then crashed by 69.89% to $37.7 million in 2023, then surged by 129.08% to $86.3 million in 2024, then tumbled by 80.88% to $16.5 million in 2025, then skyrocketed by 108.34% to $34.4 million in 2026.
  • Business Quant data shows Short-term Investments for STAA at $34.4 million in Q1 2026, $16.5 million in Q3 2025, and $22.8 million in Q2 2025.